Study title: Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas (report for study AI404-034, published in Clinical Therapeutics)
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: CEFADROXIL | |||||
| ATC code: J01DB05 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: AI404-034 | |||||
| EudraCT number: | |||||
| Scope of study: | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |